The Fed meeting, pressure on Oracle, Target's fashion-forward renovation and more in Morning Squawk

Group 1: Federal Reserve and Market Expectations - The Federal Reserve is expected to announce an interest rate decision, with a nearly 90% chance of a 25 basis point decrease, but it may be a "hawkish cut" indicating it could be the last reduction for a while [5] - The Russell 2000 index reached all-time highs as investors anticipate a loosening in monetary policy, which typically benefits smaller companies [5] - The S&P 500 and Dow Jones Industrial Average experienced a pullback, influenced by JPMorgan Chase's forecast of higher-than-expected expenses for the next year [5] Group 2: Oracle's Earnings Report - Oracle is set to report its second quarter earnings, with a focus on its ability to finance infrastructure plans and demonstrate a sound AI-driven growth story [2][3] - Oracle shares have increased over 30% this year, despite experiencing its largest one-month drop in over two decades in October [3] Group 3: Pharmaceutical Industry Developments - Eli Lilly announced a $6 billion investment to build a manufacturing facility in Huntsville, Alabama, aimed at supporting the production of its experimental obesity pill and other drugs [6] - Pfizer has entered a $2.1 billion licensing deal with YaoPharma to develop and commercialize its obesity pill, marking a significant move into the weight-loss market following its acquisition of Metsera [7] Group 4: Retail Innovations - Target has revamped its SoHo store in New York City to enhance its position as a trend and style leader, featuring rotating merchandise and curated displays [11][12] - The redesign took four months and was aimed at reopening in time for the holiday season, reflecting Target's strategy to attract consumers' discretionary spending [12][13]